Blurbs

Analysts Are Bullish on These Healthcare Stocks: EyePoint Pharmaceuticals (EYPT), Applied Genetic Technologies (AGTC)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on EyePoint Pharmaceuticals (EYPTResearch Report), Applied Genetic Technologies (AGTCResearch Report) and Axcella Health (AXLAResearch Report) with bullish sentiments.

EyePoint Pharmaceuticals (EYPT)

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on EyePoint Pharmaceuticals today and set a price target of $25.00. The company’s shares closed last Thursday at $7.39, close to its 52-week low of $6.91.

According to TipRanks.com, Chen is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -22.1% and a 27.0% success rate. Chen covers the Healthcare sector, focusing on stocks such as Bausch + Lomb Corporation, Greenwich LifeSciences, and Kiora Pharmaceuticals.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for EyePoint Pharmaceuticals with a $23.00 average price target.

See today’s best-performing stocks on TipRanks >>

Applied Genetic Technologies (AGTC)

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Applied Genetic Technologies today and set a price target of $16.00. The company’s shares closed last Thursday at $0.28, close to its 52-week low of $0.27.

According to TipRanks.com, Pantginis is ranked 0 out of 5 stars with an average return of -26.4% and a 20.5% success rate. Pantginis covers the Healthcare sector, focusing on stocks such as Bioline RX Ltd Sponsored ADR, Lineage Cell Therapeutics, and Actinium Pharmaceuticals.

Currently, the analyst consensus on Applied Genetic Technologies is a Moderate Buy with an average price target of $16.00.

Axcella Health (AXLA)

Wedbush analyst Liana Moussatos reiterated a Buy rating on Axcella Health today and set a price target of $9.00. The company’s shares closed last Thursday at $1.93.

According to TipRanks.com, Moussatos is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -9.9% and a 30.8% success rate. Moussatos covers the Healthcare sector, focusing on stocks such as Aquestive Therapeutics, Pacira Pharmaceuticals, and Liquidia Technologies.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Axcella Health with a $8.00 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on EYPT:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos